Archive: Company News
Company News: BioNTech to Present at 36th Annual J.P. Morgan Healthcare Conference
BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that Sean Marett, COO of BioNTech, will be presenting at the 36th Annual J.P. Morgan Healthcare Conference that is being held in San Francisco, CA from January 8-11, 2018. The Company’s presentation is scheduled for Tuesday, January 9 at 9:00 AM Pacific Standard Time.
Company News: Curetis To Attend Key Investor and Scientific Conferences In The First Quarter 2018
Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that the Company is going to attend several industry conferences in the first quarter of 2018.
Company News: ISA Pharmaceuticals and Regeneron Announce Strategic Immuno-Oncology Collaboration
ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a clinical collaboration to advance ISA101, an immunotherapy targeting human papillomavirus type 16 (HPV16)-induced cancer, in combination with cemiplimab (REGN2810), a PD-1 (programmed cell death protein 1) antibody. Regeneron and ISA will jointly fund and conduct clinical trials of the combination treatment in cervical cancer and head-and-neck cancer.
Company News: Provecs Medical Announces Publication of Scientific Review of Gene Therapy in Oncology
— Peer-reviewed paper in Human Gene Therapy provides comprehensive overview of using gene therapy to address multiple targets
Provecs Medical GmbH, a cancer immunotherapy company developing novel treatments to modulate the tumor microenvironment, today announced the publication of a review highlighting the use of gene therapy approaches in immuno-oncology to address multiple targets with a single drug. The paper entitled “Immuno-Oncology – the Translational Runway for Gene Therapy” will appear in the December issue of Human Gene Therapy, a peer-reviewed publication covering all aspects of human gene therapy.